Three H2020 funded projects in the field of TB vaccine research & development, TBVAC2020, EMI-TB and STriTuVad, organise a joint workshop on 8 October 2019 in Brussels “Maintaining European scientific excellence and global leadership in TB Vaccine R&D”, the Impact of 3 EU funded TB vaccine Research and Innovation projects on the global TB vaccine pipeline.

This meeting brings together scientists, policy makers, funders and other key stakeholders in TB vaccine research and innovation (R&I). The results and impact of three H2020 TB projects (TBVAC2020, EMI-TB and Strituvad) on the TB vaccine field and the TB vaccine pipeline will be presented. Meeting participants will be asked to contribute to priority policy relevant recommendations as to how the collaborative research effort that underpins these results, can be taken forward in the next two years and imbedded in FP9.

For further information please visit the TuBerculosis Vaccine Initiative's site.